1. Home
  2. MXCT vs PBPB Comparison

MXCT vs PBPB Comparison

Compare MXCT & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • PBPB
  • Stock Information
  • Founded
  • MXCT 1999
  • PBPB 1977
  • Country
  • MXCT United States
  • PBPB United States
  • Employees
  • MXCT N/A
  • PBPB N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PBPB Restaurants
  • Sector
  • MXCT Health Care
  • PBPB Consumer Discretionary
  • Exchange
  • MXCT Nasdaq
  • PBPB Nasdaq
  • Market Cap
  • MXCT 375.0M
  • PBPB 313.6M
  • IPO Year
  • MXCT 2021
  • PBPB 2013
  • Fundamental
  • Price
  • MXCT $4.24
  • PBPB $9.02
  • Analyst Decision
  • MXCT Strong Buy
  • PBPB Strong Buy
  • Analyst Count
  • MXCT 2
  • PBPB 3
  • Target Price
  • MXCT $9.50
  • PBPB $15.67
  • AVG Volume (30 Days)
  • MXCT 704.7K
  • PBPB 120.5K
  • Earning Date
  • MXCT 11-06-2024
  • PBPB 11-07-2024
  • Dividend Yield
  • MXCT N/A
  • PBPB N/A
  • EPS Growth
  • MXCT N/A
  • PBPB 641.95
  • EPS
  • MXCT N/A
  • PBPB 1.25
  • Revenue
  • MXCT $45,599,000.00
  • PBPB $471,719,000.00
  • Revenue This Year
  • MXCT N/A
  • PBPB N/A
  • Revenue Next Year
  • MXCT $21.27
  • PBPB $3.71
  • P/E Ratio
  • MXCT N/A
  • PBPB $7.22
  • Revenue Growth
  • MXCT 19.85
  • PBPB N/A
  • 52 Week Low
  • MXCT $3.17
  • PBPB $6.28
  • 52 Week High
  • MXCT $5.55
  • PBPB $14.36
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 60.65
  • PBPB 38.55
  • Support Level
  • MXCT $3.98
  • PBPB $9.60
  • Resistance Level
  • MXCT $4.55
  • PBPB $10.19
  • Average True Range (ATR)
  • MXCT 0.26
  • PBPB 0.34
  • MACD
  • MXCT 0.03
  • PBPB -0.18
  • Stochastic Oscillator
  • MXCT 70.62
  • PBPB 2.65

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

Share on Social Networks: